Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10
Article in Pharmacological Research (November 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Pharmacological Research (November 2023)
Article in Frontiers in Immunology (November 2022)